ArticleInternational journal of nanomedicine2025
Nano-Biomimetic Fibronectin/Lysostaphin-Co-Loaded Silk Fibroin Dressing Accelerates Full-Thickness Wound Healing via ECM-Mimicking Microarchitecture and Dual-Function Modulation.
Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Smart Healing for Wound Repair: Emerging Multifunctional Strategies in Personalized Regenerative Medicine and Their Relevance to Orthopedics.Antibiotics (Basel, Switzerland) · 2026Review
- "Comparative Evaluation of Saussurea Lappa Root Extract Ointment and Standard Therapy on Second-Degree Burn Wound Healing in Rabbits".Journal of experimental pharmacology · 2026Article
- Applications of Fibronectin in Biomedicine and Cosmetics: A Review.Bioengineering (Basel, Switzerland) · 2025Review
- Silk Fibroin-Derived Smart Living Hydrogels for Regenerative Medicine and Organoid Engineering: Bioactive, Adaptive, and Clinically Translatable Platforms.Gels (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: In cases of large-area skin defects, the absence of extracellular matrix can lead to difficulties in fibroblast migration, thereby hindering wound healing. This study aimed to address the challenges in treating skin defects by developing a biomimetic nano-dressing that both has antibacterial properties and promotes healing by mimicking the extracellular matrix. Patients and Methods: The electrospun silk protein nanofibers were ultrasonically fragmented into staple fibers. These were then coated and modified by adding a collagen (Col) solution loaded with recombinant lysostaphin (rLys) and fibronectin (Fn), ultimately constructing a biomimetic nanosponge (Fn-rLys-Col/SF-S). Results: In vitro studies have shown that Fn-rLys-Col/SF-S possesses good water vapor balance and antibacterial properties, is non-toxic to cells, and can promote cell proliferation and migration. In vivo experimental results indicated that Fn-rLys-Col/SF-S healed a week earlier than the control group, with the structure of the newly formed skin resembling normal skin at 21 days. Further immunohistochemistry and qRT-PCR results demonstrated that Fn-rLys-Col/SF-S effectively promotes the healing of skin defect wounds by reducing inflammation, promoting angiogenesis, enhancing collagen deposition, and regulating the degree of fibrosis. Conclusion: In conclusion, the Fn-rLys-Col/SF-S biomimetic sponge dressing can promote the repair of skin defects by mimicking the extracellular matrix, providing a potential therapeutic strategy for clinical wound treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.